Axsome Therapeutics : AXSM

Price Target $327 ↑54.8%

›

AXSM

Stock Data

$212.74

$2.61 (1.24%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Axsome Therapeutics Inc is a New York-based biopharmaceutical company focused on developing innovative treatments for central nervous system disorders. Its product lineup includes Auvelity for major depressive disorder and Sunosi for narcolepsy or obstructive sleep apnea-related daytime sleepiness. The company is also advancing several drugs through clinical trials, targeting conditions like Alzheimer's disease agitation, migraine, narcolepsy, fibromyalgia, and more. Axsome's commitment to addressing unmet medical needs in mental health and neurological conditions underscores its research-driven approach.

Latest Activity

AXSMAxsome Therapeutics, Inc.

Reports Mon Aug 10Before open7:00 AM ETConfirmed

5:00am ET

Axsome reports at 7:00 AM ET, confirmed, and the whole $10.9 billion valuation rides on Auvelity and Sunosi prescription growth holding pace with consensus. Guidance commentary here also sets the tone for the rest of the CNS group.